Real-Life Impact of Drug Toxicity on Dolutegravir Tolerability: Clinical Practice Data from a Multicenter Italian Cohort

Dolutegravir (DTG) is currently one of the most used Integrase inhibitors (INI) in antiretroviral therapies (ARV) in both naïve and experienced people living with HIV (PLWHIV). We analyzed a multicenter cohort of PLWHIV, both naïve and experienced, starting an ARV including DTG. We enrolled 3775 PLW...

Descripción completa

Detalles Bibliográficos
Autores principales: Ciccullo, Arturo, Baldin, Gianmaria, Borghi, Vanni, Lagi, Filippo, Latini, Alessandra, d’Ettorre, Gabriella, Oreni, Letizia, Fusco, Paolo, Capetti, Amedeo, Fabbiani, Massimiliano, Giacomelli, Andrea, Grimaldi, Alessandro, Madeddu, Giordano, Sterrantino, Gaetana, Mussini, Cristina, Di Giambenedetto, Simona
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8778073/
https://www.ncbi.nlm.nih.gov/pubmed/35062367
http://dx.doi.org/10.3390/v14010163

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8778073/
https://www.ncbi.nlm.nih.gov/pubmed/35062367
http://dx.doi.org/10.3390/v14010163

Ejemplares similares